Study for the Analysis of Vibrio Vulnificus strain
THIS IS NOT A REQUEST FOR QUOTATIONS. This is a notice of intent to award a sole source Firm Fixed-Price Contract.
The Food and Drug Administration's Office of Acquisition and Grant Services intends to issue a sole source award to Dr. Paul Gulig, University of Florida, Gainesville, FL for the purchase of a Study for the Analysis of Vibrio Vulnificus strain.
Functional Specifications include:
1. Virulence assessment: Task will involve laboratory analysis of individual V. vulnificus strains in a mouse model following standard laboratory protocols.
2. Data reporting: The contractor shall provide, in writing all raw data generated from the laboratory analyses.
3. Interpretations: In addition to the raw data provided, the contractor shall provide their expert interpretation of that data. Including, but not limited to, determination if each strains should be considered virulent, attenuated, or avirulent.
The NAICSs code for this requirement is 541690 Other Scientific and Technical Consulting Services.
This notice of intent is not a request for competitive proposals. The proposed action is for services for which the Government intends to solicit and negotiate with only one source under the authority of 41 U.S.C. 253(c)(1), FAR 6.302-1(a)(2). The estimated dollar value for this action is not to exceed $30,000. This will result in a contract for a one year. The projected award date is July 28, 2014.
Interested parties may submit a capability statement by July 18, 2014, 4:30 pm ET for considerations by the agency. Responses must be sent to Juana Quinteros via email at [email protected]. All correspondence must reference FDA-RFI-1134482.
Juana Quinteros, Phone 3018276764, Email [email protected]
